Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial-Reference-Cited by-同舟云学术

Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

Published:2016-05 Issue:5 Volume:17 Page:642-650
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Planchard David,Kim Tae Min,Mazieres Julien,Quoix Elisabeth,Riely Gregory,Barlesi Fabrice,Souquet Pierre-Jean,Smit Egbert F,Groen Harry J M,Kelly Ronan J,Cho B C,Socinski Mark A,Pandite Lini,Nase Christine,Ma Bo,D'Amelio Anthony,Mookerjee Bijoyesh,Curtis C Martin,Johnson Bruce E

Publisher

Elsevier BV

Subject

Oncology

Reference36 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

3. Missense mutations of the BRAF gene in human lung adenocarcinoma;Naoki;Cancer Res,2002

4. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF;Wan;Cell,2004

5. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors;Dankort;Genes Dev,2007

Cited by 340 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data;Frontiers in Oncology;2024-01-31

2. Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer;British Journal of Cancer;2024-01-04

3. Other molecular cohorts including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS;Lung Cancer;2024

4. Clinical Response of Advanced Lung Adenocarcinoma with Class III BRAF G466V Missense Mutation to Dabrafenib and Trametinib: A Case Report;OncoTargets and Therapy;2024-01

5. SH003 enhances the anti-cancer effects of Dabrafenib on lung cancer harboring BRAF G469A mutation by inhibiting the MAPK signaling pathway;2023-12-04